2026-08-11T08:03:05-05:00 2025-12-31 410746749 CLIFTONLARSONALLEN LLP 150 S WARNER ROAD SUITE 310 KING OF PRUSSIA PA 19406 990EZ 2025-01-01 812901344 GE2P2 GLOBAL FOUNDATION GE2P 2677144460 605 WEST UPSAL STREET 300 PHILADELPHIA PA 19119 DAVID R CURRY CEO, PRESIDENT, TREASURER 2677144460 2026-08-05 1 CONNIE M LIRA P00481097 2156433900 2026-08-05 2025 2025-03-06 01:10:19Z X WWW.GE2P2.ORG X X 40025 X 40025 40025 24135 37316 61451 -21426 -19608 11000 -30034 X 5236 1008 11998 1000 17234 2008 36842 32042 -19608 -30034 X THE MISSION OF GE2P2 GLOBAL FOUNDATION (FOUNDATION) IS TO ADVANCE ETHICAL AND SCIENTIFIC RIGOR IN RESEARCH AND EVIDENCE GENERATION . . . STRENGTHENING GOVERNANCE, POLICY AND PRACTICE . . . INFORMING HUMAN RIGHTS ACTION, HUMANITARIAN RESPONSE, HEALTH, EDUCATION, HERITAGE STEWARDSHIP, AND SUSTAINABLE DEVELOPMENT . . . DELIVERED BY GOVERNMENTS, INTERNATIONAL AGENCIES, INGOS, CIVIL SOCIETY ORGANIZATIONS (CSOS), COMMERCIAL ENTITIES, CONSORTIA AND ALLIANCES, AND INDIVIDUALS. THE FOUNDATION OPERATES THROUGH A PORTFOLIO OF CENTERS AND PROGRAMS TO FOCUS THE WORK AND ENGAGES THE COMPETENCIES, EXPERIENCE, AND INSIGHTS OF A GLOBAL NETWORK OF ELECTED "FELLOWS" OF THE FOUNDATION. FELLOWS INCLUDE ACADEMIC, AGENCY AND GOVERNMENT LEADERS, SCIENTISTS, RESEARCHERS, ETHICISTS, FIELD PRACTITIONERS, DOMAIN AND CULTURAL CONTEXT EXPERTS, SCHOLARS IN THE SOCIAL AND BIOSCIENCES AND THE HUMANITIES, KNOWLEDGE MANAGEMENT EXPERTS, AND MANY OTHERS. DURING 2025, THE FOLLOWING CENTERS WERE ACTIVE: (1) CENTER FOR VACCINE ETHICS AND POLICY (CVEP), (2) CENTER FOR INFORMED CONSENT INTEGRITY (CICI), (3) CENTER FOR DISASTER AND HUMANITARIAN ETHICS (CDHE), (4) INDEPENDENT BIOETHICS ADVISORY COMMITTEE (IBAC), AND (5) CENTER FOR GENOMIC MEDICINE ETHICS AND POLICY (CGMEP).(1) CVEP ENGAGES THE FULL LIFE-CYCLE OF ISSUES AROUND GLOBAL IMMUNIZATION AND VACCINES -- BUILDING AND REFINING ETHICAL FRAMEWORKS; ANALYZING AND COMMUNICATING ABOUT VACCINE EVIDENCE, ETHICS AND POLICY; INNOVATING NEW ANALYTICAL, VISUALIZATION AND DECISION APPROACHES AND CONVENING THE VACCINE COMMUNITY TO CONSIDER EVIDENCE, ETHICS AND PRACTICAL SOLUTIONS. CVEP ALSO OFFERS A KNOWLEDGE-SHARING SERVICE THROUGH PUBLICATION OF VACCINES AND GLOBAL HEALTH: THE WEEK IN REVIEW. THIS COMPREHENSIVE WEEKLY DIGEST AGGREGATES NEWS, EVENTS, ANNOUNCEMENTS, PEER-REVIEWED ARTICLES AND RESEARCH IN THE GLOBAL VACCINE ETHICS AND POLICY SPACE.(2) CICI ADDRESSES INFORMED CONSENT BROADLY AND HOLDS THAT "CONSENT" GROUNDED IN OPEN, EVIDENCE-BASED, ACCESSIBLE, UNDERSTANDABLE AND MATERIALLY-COMPLETE INFORMATION IS THE BULWARK OF HUMAN RIGHTS, FUNDAMENTAL FREEDOMS, AND RESPONSIBLE GOVERNANCE. THE CENTER FOCUSES ON CONSENT IN RESEARCH CONTEXTS ACROSS ALL THE FOUNDATION'S ACTION SECTORS INCLUDING HEALTH, HUMAN RIGHTS, HUMANITARIAN RESPONSE, EDUCATION AND LITERACY, SUSTAINABLE DEVELOPMENT, AND HERITAGE STEWARDSHIP. THIS WORK INCLUDES PRODUCING KNOWLEDGE SHARING SERVICES AND ADVISORY SERVICES SUPPORTING DEVELOPMENT AND IMPLEMENTATION OF RESPONSIBLE CONSENT AND ASSENT PRACTICES. (3) CDHE FOCUSES ON ETHICS, EVIDENCE GENERATION, AND POLICY INVOLVING HEALTH INTERVENTIONS PARTICULARLY IMMUNIZATION HUMAN RIGHTS, AND OVERALL HUMANITARIAN RESPONSE TO THE FULL RANGE OF COMPLEX EMERGENCIES, FRAGILE CONFLICT-VIOLENCE (FCV) CONTEXTS, AND NATURAL AND MANMADE DISASTERS.(4) IBAC PROVIDES RESEARCH, ANALYSIS AND ADVISORY ANALYSIS AND RECOMMENDATIONS ON ISSUES WHICH MAY ARISE ACROSS THE LIFE CYCLE OF CLINICAL RESEARCH AND EVIDENCE GENERATION BASED ON ITS TRIAD APPROACH CONSIDERING MEDICAL RESPONSIBILITY, OPERATIONAL SOUNDNESS, AND ETHICAL RESILIENCE.(5) CGMEP FOCUSES ON GENOMICS, GENE EDITING, AND THE WIDER ECOLOGY OF CONVERGENT BIOSCIENCES SPANNING AI- AND DATA-ENABLED DISCOVERY, INTEGRATED MULTI-OMICS, SYNTHETIC AND ENGINEERING BIOLOGY, ADVANCED CELLULAR AND TISSUE MODELLING INCLUDING ORGANOIDS, NEUROTECHNOLOGIES, SYSTEMS AND PREDICTIVE BIOSCIENCES, AND TRANSLATIONAL AND PRECISION HEALTH. THE CENTER EXAMINES GOVERNANCE, ETHICS AND POLICY ACROSS THIS COMPLEX AND RAPIDLY EVOLVING FIELD. 0 52076 52076 JESTINA DOE ANDERSON PHD DIRECTOR 1.00 0 0 0 ROBERT I FIELD PHD MPH JD DIRECTOR 1.00 0 0 0 ROSS UPSHUR BA HONS MA MD MSC DIRECTOR 1.00 0 0 0 PROF DR FERNANDO LOLAS STEPKE DIRECTOR 1.00 0 0 0 DAVID R CURRY MS CEO, PRESIDENT, TREASURER 8.00 0 0 0 KRISTIN A FEEMSTER MD MPH MSHPR SECRETARY 1.00 0 0 0 X 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CA CT DC MA MD NJ NY PA VA WA THE ORGANIZATION 605 WEST UPSAL STREET 300 PHILADELPHIA PA 19119 2677144460 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 94525 69535 62100 77150 40025 343335 94525 69535 62100 77150 40025 343335 263431 79904 343335 15000 0.23270 0.25650 X THE GE2P2 GLOBAL FOUNDATION WAS FORMED AND APPROVED AS A 501(C)(3) CHARITABLE ORGANIZATION IN 2016 AND HAS PURSUED A FOCUSED, TECHNICAL CHARITABLE PURPOSE: TO ADVANCE SCIENTIFIC RIGOR, ETHICAL RESILIENCE AND INTEGRITY IN RESEARCH AND EVIDENCE GENERATION ACROSS THE SCIENCES, HUMANITIES AND OTHER SECTORS, INFORMING GOVERNANCE, POLICY AND PRACTICE.SINCE ITS FOUNDING, THE FOUNDATION'S GOVERNANCE HAS BEEN FOCUSED ON BUILDING AWARENESS AND DEVELOPING AND DELIVERING INNOVATIVE PROGRAMS AND SERVICES TO GLOBAL AND NATIONAL ORGANIZATIONS IN THIS HIGHLY TECHNICAL AREA COMPRISING BIOETHICS, MEDICAL ETHICS, SCIENTIFIC METHODOLOGIES, AND RESEARCH INTEGRITY.KEY TO THIS AWARENESS BUILDING HAS BEEN A SERIES OF KNOWLEDGESHARING PUBLICATIONS REACHING A GROWING AUDIENCE OF SCIENTISTS, RESEARCHERS, AND INTERNATIONAL AGENCY, INGO [INTERNATIONAL NONGOVERNMENTAL ORGANIZATION], GOVERNMENT AND CSO [CIVIL SOCIETY ORGANIZATION] LEADERS GLOBALLY.AS A RELATIVELY NEW ORGANIZATION, THE FOUNDATION HAS MAINTAINED A CONTINUOUS AND BONA FIDE PROGRAM FOR SOLICITATIONS OF FUNDS FROM THE GENERAL COMMUNITY BUT IS STILL IN THE EARLY PHASES OF REACHING BEYOND THE EXPERTS AND SPECIALISTS REFERENCED ABOVE TO BUILD BROADBASED AWARENESS OF THE FOUNDATION'S MISSION AND PROGRAMS.SOLICITATION EFFORTS ARE CONDUCTED AND DRIVEN BY STAFF WITH THE SUPPORT OF THE VOLUNTEER BOARD, FOCUSING ESPECIALLY ON ORGANIZATIONS WITHIN THE SCIENTIFIC AND CHARITABLE COMMUNITY WHO ARE ALREADY WELL ALIGNED WITH THE TECHNICAL DIMENSIONS OF THE FOUNDATION'S PROGRAMS, AND WHICH APPRECIATE THE BROAD PUBLIC GOOD THE EXEMPT PURPOSE THE FOUNDATION SERVES.TO ENGAGE THIS AWARENESS CHALLENGE, BOARD AND STAFF ARE ACTIVELY WORKING TOWARDS BRIDGING THE KNOWLEDGE AND "APPRECIATION" GAP. SPECIFICALLY, A PROGRAM TO INTEGRATE A RANGE OF SOCIAL MEDIA CHANNELS INTO OVERALL AWARENESS EFFORTS CONTINUED THROUGH 2025 AND WILL EXPAND GOING ONWARD. FURTHER, THE FOUNDATION INITIATED A NEW PROGRAM OF ANALYSIS AND PUBLIC COMMENTARY DURING 2025 TO ENGAGE GROWING ISSUES IN SCIENTIFIC AND RESEARCH INTEGRITY IN THE U.S. AND GLOBALLY. WHILE THESE STRATEGIES HAVE NOT YET YIELDED ANY SIGNIFICANT INCREASE IN THE PUBLIC SUPPORT PERCENTAGE FROM 2022 TO 2025, THE FOUNDATION WILL CONTINUE TO EXPLORE STRATEGIES TO STRENGTHEN PUBLIC AWARENESS OF ITS MISSION AND PROGRAMS IN 2026 AND BEYOND, MATERIALLY IMPROVING ITS PERFORMANCE UNDER THE PUBLIC SUPPORT TEST. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES DESCRIPTION: INFORMATION TECHNOLOGY. AMOUNT: 4,881. DESCRIPTION: INSURANCE. AMOUNT: 2,302. DESCRIPTION: DUES AND SUBSCRIPTIONS. AMOUNT: 1,999. DESCRIPTION: LICENSES AND REGISTRATIONS. AMOUNT: 2,723. DESCRIPTION: BANK AND CREDIT CARD FEES. AMOUNT: 2,411. DESCRIPTION: FELLOWSHIPS AND HONORARIUMS. AMOUNT: 23,000. TOTAL TO FORM 990-EZ, LINE 16: 37,316. FORM 990-EZ, PART I, LINE 20 - OTHER CHANGES IN NET ASSETS DESCRIPTION: IN-KIND SERVICES. AMOUNT: 11,000. FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS DESCRIPTION: ACCOUNTS RECEIVABLE. BEG. OF YEAR AMOUNT: 10,500. END OF YEAR AMOUNT: 0. DESCRIPTION: INVESTMENT IN PBC. BEG. OF YEAR AMOUNT: 1,000. END OF YEAR AMOUNT: 1,000. DESCRIPTION: PREPAID EXPENSES. BEG. OF YEAR AMOUNT: 498. END OF YEAR AMOUNT: 0. FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES DESCRIPTION: ACCOUNTS PAYABLE. BEG. OF YEAR AMOUNT: 36,842. END OF YEAR AMOUNT: 32,042. THE ORGANIZATION DID NOT, DURING THE YEAR, RECEIVE ANY FUNDS, DIRECTLY,OR INDIRECTLY, TO PAY PREMIUMS ON A PERSONAL BENEFIT CONTRACT.THE ORGANIZATION, DID NOT, DURING THE YEAR, PAY ANY PREMIUMS, DIRECTLY,OR INDIRECTLY, ON A PERSONAL BENEFIT CONTRACT.